Carregant...

The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma

RBM10 is the RNA-binding protein often absent or mutated in lung adenocarcinoma, rendering it as a potential biomarker or even therapeutic target to prolongate survival time. In this study, we investigated the involvement of RBM10 mutation in the pathogenesis and tumorigenesis of lung adenocarcinoma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Cycle
Autors principals: Li, Zhenqing, Xue, Qun, Xu, Jianxun, Zhang, Pengfei, Ding, Bo
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7714495/
https://ncbi.nlm.nih.gov/pubmed/33064970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1829801
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!